Visually Enhanced Education About Prostate Cancer
Study Details
Study Description
Brief Summary
This randomized clinical trial studies how well visually enhanced education works in improving prostate cancer and treatment knowledge in patients with prostate cancer that has not spread to other places in the body. Visually enhanced education includes pictures, drawings, and photos, may help doctors better convey information about radiation and prostate cancer to patients.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
PRIMARY OBJECTIVES:
- Our goal is to conduct a randomized controlled trial to determine the impact of a visual presentation in the context of a radiation oncologist's discussion with patient during consultation on patient satisfaction at end of consultation visit and at end of treatment, on anxiety at start of treatment, on decision regret following treatment, and on perception of side effects following treatment. Of note, the attending radiation oncologist will be responsible for reviewing the Powerpoint presentation with the patient, taking time to answer any questions that the patient has
OUTLINE: Patients are randomized into 1 of 2 arms.
ARM A (STANDARD EDUCATION): Patients receive a standard prostate cancer radiation oncology consultation.
ARM B (VISUAL ENHANCED EDUCATION): Patients receive a visually enhanced prostate cancer educational Powerpoint presentation including prostate anatomy, pathologic results, surgical options, radiation therapy, and prognosis with pictographs during radiation oncology consultation.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: Standard Education Patients receive standard-of-care prostate cancer radiation oncology consultation. |
Other: Standard prostate cancer education presentation
Receive standard prostate cancer education presentation
|
| Experimental: Visually Enhanced Education Patients receive a visually enhanced prostate cancer educational Powerpoint presentation including prostate anatomy, pathologic results, surgical options, radiation therapy, and prognosis with pictographs during radiation oncology consultation. |
Other: Visually enhanced prostate cancer educational presentation
Receive visually enhanced prostate cancer educational presentation
|
Outcome Measures
Primary Outcome Measures
- Decision-Regret - based on Ottawa scale [Up to 12 weeks]
Sample size was determined based on this primary outcome - with estimated mean of 16 in Arm A and mean of 8 in Arm B, with standard deviation of 15, with 80% power and alpha of 0.05.
Secondary Outcome Measures
- Satisfaction - SCA [baseline, end of treatment, and long-term follow-up]
- Symptoms based on EPIC-26 short form [baseline, end of treatment, and long-term follow-up]
- Anxiety - Memorial MAX-PC scale [1 week]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patient must have non-metastatic, biopsy proven prostate cancer
-
Must be referred to radiation oncology clinic
Exclusion Criteria:
-
Prior surgery or radiation therapy for prostate cancer
-
Patients who are blind are excluded
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Vanderbilt University Medical Center | Nashville | Tennessee | United States | 37203 |
Sponsors and Collaborators
- Vanderbilt-Ingram Cancer Center
- National Cancer Institute (NCI)
Investigators
- Principal Investigator: Austin Kirschner, MD, Vanderbilt University
Study Documents (Full-Text)
More Information
Publications
None provided.- VICC RAD 1646
- NCI-2016-00777